The second edition of The Signature, the WVU Cancer Institute’s annual report, is posted online.
The report covers 2016 highlights in cancer clinical care, prevention and control, education, and research. Special topics highlighting quality care and the latest developments of the WVU Cancer Institute include:
- a Q & A with new Cancer Institute Director Richard Goldberg
- our growth as a statewide network of cancer care
- two unique lung cancer initiatives the Cancer Institute is leading in WV
- a look at the new, state-of-the-art Bonnie’s Bus
- an innovative approach to move effective treatments from the lab to clinical research studies
- an overview of academic programs to train aspiring physicians and scientists
The WVU Cancer Institute is participating in the implementation of a new drug therapy for young patients with leukemia and lymphoma. Chimeric Antigen Receptor (CAR) T-cell therapy, known by the brand name Kymriah®, is a form of immunotherapy that harnesses the patient’s own immune system to fight malignant cancer.
Defense Health Program
The WVU Cancer Institute is applying for a Certificate of Need with the West Virginia Health Care Authority for a mobile lung cancer screening program, which will be called LUCAS. This program would increase access to screening for patients in rural areas and address the growing demand for cancer services in the state.